CAD 0.17
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -710 Thousand CAD | 47.91% |
2022 | -1.36 Million CAD | 77.33% |
2021 | -6.01 Million CAD | 35.08% |
2020 | -9.26 Million CAD | 40.99% |
2019 | -15.69 Million CAD | 13.76% |
2018 | -18.19 Million CAD | -28.2% |
2017 | -14.19 Million CAD | -108.2% |
2016 | -6.81 Million CAD | -14640.26% |
2015 | -46.25 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 Q3 | -179 Thousand CAD | 63.17% |
2023 Q4 | -316 Thousand CAD | -76.54% |
2023 Q2 | -486 Thousand CAD | -280.0% |
2023 Q1 | 270 Thousand CAD | 40.63% |
2022 Q3 | -628 Thousand CAD | -60.61% |
2022 Q4 | 192 Thousand CAD | 130.57% |
2022 Q2 | -391 Thousand CAD | 26.78% |
2022 FY | -1.36 Million CAD | 77.33% |
2022 Q1 | -534 Thousand CAD | 66.67% |
2021 Q1 | -1.46 Million CAD | 0.0% |
2021 FY | -6.01 Million CAD | 35.08% |
2021 Q4 | -1.6 Million CAD | -31.64% |
2021 Q3 | -1.21 Million CAD | 29.61% |
2021 Q2 | -1.72 Million CAD | -18.1% |
2020 FY | -9.26 Million CAD | 40.99% |
2019 FY | -15.69 Million CAD | 13.76% |
2018 FY | -18.19 Million CAD | -28.2% |
2017 FY | -14.19 Million CAD | -108.2% |
2016 FY | -6.81 Million CAD | -14640.26% |
2015 FY | -46.25 Thousand CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | -2.82 Million CAD | 74.825% |
CanadaBis Capital Inc. | 4.67 Million CAD | 115.181% |
Decibel Cannabis Company Inc. | 1.41 Million CAD | 150.283% |
Entourage Health Corp. | -21.37 Million CAD | 96.679% |
Lifeist Wellness Inc. | -12.24 Million CAD | 94.204% |
Cannara Biotech Inc. | 11.88 Million CAD | 105.973% |
Medicure Inc. | -854 Thousand CAD | 16.862% |
PharmaCielo Ltd. | -9.7 Million CAD | 92.681% |
Rubicon Organics Inc. | -1.08 Million CAD | 34.468% |
BioSyent Inc. | 7.47 Million CAD | 109.503% |
Voyageur Pharmaceuticals Ltd. | -1.22 Million CAD | 41.849% |